Lack Of Competition Thwarts Roche’s PPMS Bid For Ocrevus At UK’s NICE

 
• By Francesca Bruce

Roche’s Ocrevus is having a rough ride through NICE, the UK health technology appraisal body, because there are no other treatments available to slow down the disease, says the company.

Multiple sclerosis
NICE Declines To Recommend Roche's Ocrevus In PPMS • Source: Shutterstock

More from Europe

More from Geography